(Q39866698)

15 September 2017

Susceptibility of Mycobacterium kansasii to ofloxacin, sparfloxacin, clarithromycin, azithromycin, and fusidic acid (English)

1 reference

15 September 2017

0 references

1 reference

1 reference

Mycobacterium kansasii

object named as

Mycobacterium kansasii

1 reference

Witzig RS

1

1 reference

15 September 2017

Franzblau SG

series ordinal

2

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 September 1993

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

37

1 reference

15 September 2017

9

1 reference

15 September 2017

1997-1999

1 reference

Antimycobacterial activities in vitro and in vivo and pharmacokinetics of dihydromycoplanecin A

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Mycobacteria and the new quinolones

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Comparative in-vitro activities of ten fluoroquinolones and fusidic acid against Mycobacterium spp

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Susceptibility of mycobacteria to fusidic acid

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Fusidic acid is highly active against extracellular and intracellular Mycobacterium leprae

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Effect of pH on radiometric MICs of clarithromycin against 18 species of mycobacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

The site concentrations of antimicrobial agents in the lung

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

In vitro susceptibility of Mycobacterium kansasii to clarithromycin

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Comparative in-vitro activity of five fluoroquinolones against mycobacteria

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

In vitro determination of the sensitivity of mycobacteria to fluoroquinolones

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Effects of environmental factors on the in vitro potency of azithromycin.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Susceptibility of strains of the Mycobacterium tuberculosis complex to fusidic acid.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

Evaluation of new anti-infective drugs for the treatment of disease caused by Mycobacterium kansasii and other mycobacteria. Infectious Diseases Society of America and the Food and Drug Administration

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=188108

The course of untreated Mycobacterium kansasii disease

17 June 2018

1 reference

12 December 2020

Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii

1 reference

12 December 2020

Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice

1 reference

12 December 2020

[Bactericidal activity of ofloxacin against Mycobacterium kansasii]

1 reference

12 December 2020

Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience

1 reference

12 December 2020

Comparative in vitro activity of the new macrolide A-56268 against mycobacteria

1 reference

12 December 2020

The pharmacokinetics of azithromycin in human serum and tissues

1 reference

12 December 2020

Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.37.9.1997

1 reference

release_7ieszyrgsfeu5lsid4kzk3eacm

15 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7ieszyrgsfeu5lsid4kzk3eacm

24 November 2022

mapped directly with Wikidata item

1 reference

15 September 2017

PubMed publication ID

8239620

1 reference